ViroAb™ Mouse Anti-Dengue Virus Type 2 NS5 Monoclonal Antibody (XX0121)

Search All

Virus Antibodies

Pseudovirus

Secondary Antibodies

Isotype Controls

Virology Probe

Vaccine Serum

Documents

Datasheet
MSDS
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
Tech Support

Cat#: VRS-0224-YT1303

ViroAb™ Mouse Anti-Dengue Virus Type 2 NS5 Monoclonal Antibody (XX0121)

This Mouse Monoclonal antibody is specific for Dengue virus Type 2 protein. The antibody can be used for applications: WB, ICC/IF. The antibody is for Dengue fever disease research use only and is not approved for use in humans or clinical diagnosis.

Made to Order Requirements

Your choose infomation:

CLEAR

(Note: Please select the requirements to fit you project. If you have any other requirements, please specify. If no specific requirements, you don't need to select any button.)

Product Overview
Product Properties
Packaging, Storage & Formulations
Applications

Product Overview

Target :	NS5
Specificity :	This antibody reacts with non-structural protein 5 of Dengue virus Type 2.
Clone :	XX0121
Host Species :	Mouse
Antibody Isotype :	IgG1
Species Reactivity :	Dengue Virus 2

Product Properties

Immunogen :	Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of Dengue virus Type 2 NS5 protein. The exact sequence is proprietary.
Purity :	>95% as determined by SDS-PAGE
Purification :	Protein G affinity chromatography
Concentration :	1.0 mg/mL (lot specific)

Packaging, Storage & Formulations

Form :	Liquid
Formulation :	PBS

Applications

Application :	WB; ICC; IF
Application Notes :	WB 1:1000-1:10000. ICC/IF 1:100-1:2000. The optimal working dilutions should be determined by the end user.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

pepFastX™ Platform

If no antibody is available for your research, we recommend our novel pepFastX™ antibody discovery platform. The mAb products can be delivered within 2-3 months.

Learn more